PIANIGIANI, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 187
NA - Nord America 162
EU - Europa 140
SA - Sud America 24
AF - Africa 2
Totale 515
Nazione #
US - Stati Uniti d'America 160
SG - Singapore 77
IT - Italia 61
VN - Vietnam 32
CN - Cina 31
IE - Irlanda 30
HK - Hong Kong 27
BR - Brasile 19
KR - Corea 13
RU - Federazione Russa 12
DE - Germania 9
FI - Finlandia 9
AR - Argentina 4
LT - Lituania 3
NL - Olanda 3
AT - Austria 2
BD - Bangladesh 2
FR - Francia 2
GB - Regno Unito 2
PL - Polonia 2
SE - Svezia 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
CA - Canada 1
CH - Svizzera 1
ES - Italia 1
IN - India 1
JP - Giappone 1
MX - Messico 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
TR - Turchia 1
Totale 515
Città #
Singapore 52
Perugia 32
Dublin 30
Dong Ket 28
Hong Kong 27
Chandler 22
Boardman 15
Ashburn 14
Seoul 13
Los Angeles 11
Santa Clara 10
San Mateo 8
Turku 7
Beijing 6
Munich 5
New York 5
Altamura 4
Piscataway 4
Cagliari 3
Ho Chi Minh City 3
Medford 3
Moscow 3
Orem 3
Princeton 3
Saint Petersburg 3
Amsterdam 2
Ancona 2
Andover 2
Campobasso 2
Collazzone 2
Dallas 2
Foligno 2
Hefei 2
Johannesburg 2
Lawrence 2
Redmond 2
Redwood City 2
Rome 2
Shanghai 2
São Paulo 2
Vienna 2
Warsaw 2
Wilmington 2
Asunción 1
Baku 1
Belgioioso 1
Bologna 1
Brasília 1
Buenos Aires 1
Cachoeiras de Macacu 1
Castiglione del Lago 1
Charlotte 1
Chicago 1
Dhaka 1
Divinópolis 1
Doha 1
Duque de Caxias 1
Estrela dOeste 1
Florence 1
Fortim 1
Hanoi 1
Heliópolis 1
Helsinki 1
Itabaiana 1
Itabira 1
Jianning 1
Jinan 1
Lappeenranta 1
Lausanne 1
Lisbon 1
London 1
Mexico City 1
Monte Grande 1
Montreal 1
Newark 1
Northvale 1
Norwalk 1
Nuremberg 1
Paraná 1
Paris 1
Pelotas 1
Ponte Nova 1
Ponzano Veneto 1
Pune 1
Quilmes 1
San Francisco 1
Santa Luzia 1
Senhor do Bonfim 1
Sorocaba 1
St Louis 1
São Gabriel da Palha 1
Tampa 1
Tappahannock 1
Tokyo 1
Ubá 1
Virginia Beach 1
Totale 403
Nome #
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice 143
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 75
Current status and future perspectives in targeted therapy of NPM1-mutated AML 74
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 74
The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein 56
Response to: “Cytoplasmic dislocation of NPM1 and PU.1 in NPM1-mutated leukemia is obscured by paraformaldehyde fixation” 53
PU.1 subcellular localization in acute myeloid leukaemia with mutated NPM1 49
null 18
Totale 542
Categoria #
all - tutte 2.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.701


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 1 0 1 0 0 0 28
2021/202227 0 14 0 0 1 0 0 5 0 0 4 3
2022/202390 3 8 2 4 13 7 4 6 32 5 5 1
2023/202472 6 5 3 2 0 3 15 2 9 3 11 13
2024/2025166 8 13 6 6 16 13 33 21 21 5 16 8
2025/2026139 22 16 14 33 45 9 0 0 0 0 0 0
Totale 542